期刊文献+

非酒精性脂肪性肝病与代谢综合征组分的相关性研究进展 被引量:1

Advances of Correlation between Nonalcoholic Fatty Liver Disease and the Components of Metabolic Syndrome
原文传递
导出
摘要 非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)在全世界人群中发病率逐年上升,成为新的全球公共健康问题,已越来越引起临床关注。其发病以胰岛素抵抗为基础,与肥胖、血脂紊乱、原发性高血压、2型糖尿病等代谢综合征各组分密切相关。NAFLD可进展至肝硬化、肝衰竭甚至肝癌,伴有代谢综合征一种或多种组分可能加速疾病的进展。NAFLD初期是一种可逆性过程,充分了解影响其发生、发展的相关代谢危险因素并及时纠正,可能导致疾病的逆转或延缓其进程。本文就NAFLD与代谢综合征各组分的相关调查研究进行综述。 Nonalcoholic fatty liver disease is increasing in population all over the world. As a new global public health problem, it arouses more and more clinical concernsand not clear its pathogenesis up to now. The onset of nonalcoholic fatty liver disease is on the basis of insulin resistance while related to components of metabolic syndrome including obesity, dyslipidemia, essential hypertension and diabetes. The disease may progress to liver cirrosis, liver failure or liver cancer, one or more components of metabolic syndrome associated with NAFLD may accelerate the progress of the disease, Early NAFLD is a reversible process, fully understanding of the impact of metabolic risk factors on its occurrence and development and promptly correcting it, may result in disease reversal or slowing down its progression. which is a hot topic of research recently. This paper briefly reviewed theits progerss of the research between NAFLD and components of metabolic syndrome.
出处 《现代生物医学进展》 CAS 2014年第14期2798-2800,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81360072)
关键词 非酒精性脂肪性肝病 代谢综合征X 胰岛素抵抗 Nonalcoholic fatty liver disease Metabolic syndrome X Insulin resistance
  • 相关文献

参考文献33

  • 1Williams R. Global challenges in liver disease [J]. Hepatology, 2006, 44(3): 521-526.
  • 2Vernon G, Baranova A, Younossi ZM. Systematic review: the epidem- iology and natural history of non-alcoholic fatty liver disease and non- alcoholic steatohepatitis in adults [J]. Aliment Pharmaeol Ther, 201 1, 34(3): 274-285.
  • 3Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol, 2009, 50(1): 204-210.
  • 4Bhat G, Baba CS, Pandey A, et al. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease[J]. Trop Gastroenterol, 2013, 34(1): 18-24.
  • 5Milic S, Stimac D. Nonalcoholic fatty liver disease/steatobepatitis: epidemiology, pathogenesis, clinical presentation and treatment [J]. Dig Dis, 2012, 30(2): 158-162.
  • 6Alberti KG, Eckel RI-I, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Fed- eration Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atheroselerosis Society; and International Association for the Study of Obesity [J]. Circulation, 2009, 120(16): 1640-1645.
  • 7Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults[J]. J Clin Gastroenterol, 2006, 40(Suppl 1 ):S5-S 10.
  • 8Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations [J]. Clin Sci (Lond), 2008, 115(5):141-150.
  • 9Erickson SK. Nonalcoholic fatty liver disease[J]. J Lipid Res, 2009, 50 (Supp 1):S412-S416.
  • 10Schwimmer JB, McGreal N, Deutsch R, et al. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents [J]. Pediatrics, 2005, 115(5): e561-565.

二级参考文献13

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3060
  • 2Caldwell S, Argo C. The natural history of non - alcoholic fatty liver disease [J]. J Dig Dis, 2010, 28 (1) : 162 -168.
  • 3Trombini P, Piperno A. Ferritin, metabolic syndrome and NAFLD: e- lective attractions and dangerous liaisons [ J ]. J Hepatol, 200"7, 46 (4) : 549 -552.
  • 4The Chinese National Workshop on Fatty Liver and Alcoholic Liver Dis- ease for the Chinese Liver Disease Association. Guidelines for manage- ment of nonalcoholic fatty liver disease : an updated and revised edition [J]. J Gastroenterol Hepatol, 2010, 19 (6) : 483 -487.
  • 5Neuschwander - Tetri BA, Clark JM, Bass NM, et al. Clinical, labo- ratory and histological associations in adults with nonalcoholic fatty liver disease [J]. Hepatology, 2010, 52 (3): 913-924.
  • 6Lohsoonthom Y, Dhanamun B, Williams MA, et al. Prevalence of hy- peruicemia and its relationship with metabolic syndrome in Thai adults receiving annum health exams [J]. Arch Med Res, 2006, 37 (7) : 883 - 889.
  • 7Ryu S, Chang Y, Kim SG, et al. Serum uric acid levels predict inci- dent nonalcoholic fatty liver disease in healthy Korean men [J]. Metab- olism, 2011, 60 (6): 860-866.
  • 8Fan JG. Impact of non - alcoholic fatty liver disease on accelerated met- abolic complications [J]. J Dig Dis, 2008, 9 (2) : 63 -67.
  • 9Fan JG, Saibara T, Chittufi S, et al. What are the risk factors and settings for non -alcoholic fatty liver disease in Asia -Pacific.'? [ J ]. J Gastroenterol Hepatol, 2007, 22 (6): 794-800.
  • 10Nobili V, Sanyal AJ. Treatment of nonalcoholic fatty liver disease in a- dults and children: a closer look at the arsenal [ J ]. J Gastroenterol, 2012, 47 (1): 29-36.

共引文献12

同被引文献37

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部